Eli Lilly stock upgraded to Buy on forecast for new diabetes drug - Yahoo Finance

Diabetes Tips, News & Articles

UBS analysts upgraded Eli Lilly stock to Buy, stating that the pharma company's Type 2 diabetes medication could become a best-selling drug.
UBS analysts upgraded Eli Lilly stock to Buy, stating that the pharma company's Type 2 diabetes medication could become a best-selling drug.
Read more
Note: This news content is auto-generated from a syndicated feed.

If you have a family history of diabetes you could be at risk, get tested now! Book Diabetes test online

Popular posts from this blog

How the timing of dinner and genetics affect individuals' blood sugar control - ScienceDaily

Coronapod: COVID and diabetes, what the science says - Nature

Sciwind Biosciences Announces Initiation of Dosing in Phase 1 Clinical Trial Evaluating ...